- Funds Available for Scientific Research in Fields Relevant to Inherited Bleeding Disorders
- Location of Tenure
- Grant amount / Duration of Support
- General Conditions and Application Form
Funds Available for Scientific Research in Fields Relevant to Inherited Bleeding Disorders
The CHS Dream of a Cure Research Program, through funds provided by the Hemophilia Research Million Dollar Club and the Canadian Hemophilia Society, supports research focused on improving the health and the quality of life of all people with inherited bleeding disorders and finding a cure. The Canadian Hemophilia Society invites applicants to apply for basic scientific research grants in fields relevant to hemophilia A and B, von Willebrand disease, rare factor deficiencies, platelet function disorders (and platelet pathophysiology) and other congenital and acquired bleeding disorders.
Applicants must be Canadian citizens or permanent residents and affiliated with a Canadian university or not-for-profit health-related organization.
Location of Tenure
The research will be conducted in Canada by Canadian researchers affiliated with Canadian universities or not-for-profit health-related organizations.
Grant amount / Duration of Support
Individual grants valued at $75,000 per year and per project will be awarded to researchers for a maximum of $150,000 which can be expended over 2 or 3 years. If a two year award is provided, the second year of funding is dependent on evidence of progress as described in the required progress report. Grant funding will begin on April 1 of each year.
Yearly grants will normally be disbursed in two payments in each year.
General Conditions and Application Form
Applications must be completed and submitted electronically to the Canadian Hemophilia Society and one (1) original paper copy, including signatures, must be sent to the National Office of the Canadian Hemophilia Society:
666 Sherbrooke Street West, Suite 301
Montreal, QC H3A 1E7
Montreal, QC H3A 1E7
Please click on the following links for General Conditions and Application Form
All completed application forms and support documents must arrive at the National Office of the Canadian Hemophilia Society on or before November 15, 2016. If the CHS receives the application after the deadline date but it is postmarked on or before the deadline date, then it is considered to have been submitted on time. The names of the successful applicants will be announced by March, 2017.
Applications will be reviewed by an independent peer review committee composed of Canadian medical and healthcare professionals and a patient representative. This committee will rank the applications and will make recommendations to the CHS Board of Directors on funding of the proposals. The final decisions regarding awards will be made by the CHS Board of Directors. No appeals will be considered.